1 / 12

NQF Safe Practices Consensus Evaluation October 2003

NQF Safe Practices Consensus Evaluation October 2003. Texas Medical Institute of Technology. Subject Matter Expert Input Instructions: PROVIDE INFORMATION REQUESTED IN TABLE PROVIDED:

august
Download Presentation

NQF Safe Practices Consensus Evaluation October 2003

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. NQF Safe Practices Consensus Evaluation October 2003 Texas Medical Institute of Technology • Subject Matter Expert Input Instructions: • PROVIDE INFORMATION REQUESTED IN TABLE PROVIDED: • Fill in the sections of the table on slide # 2 with your expert interpretation and answers to the questions in the shaded area. • Slide #4 was provided for overflow information that may not all fit on slide # 2. • USE SLIDE # 3 AS YOUR NQF REFERENCE RESOURCE : • The content has been taken directly from the NQF Safe Practices Consensus Report published May 2003. • PLEASE RETURN THE FORMS BY E-MAIL TO THE LEAD PERSON DEFINED IN THE BOX ABOVE. • IF YOU HAVE ANY ADDITIONAL COMMENTS, PLEASE RECORD THEM IN THE BOX TO THE RIGHT. • IF YOU HAVE ANY QUESTIONS, PLEASE CALL OR E-MAIL THE LEAD OR ASSIST PERSONS FOR THE PRACTICE DESIGNATED ABOVE. • THE LEAD PERSON IS RESPONSIBLE TO COLLECT THE INFORMATION YOU SUBMIT AND THE ASSIST PERSON IS AVAILABLE TO ASSIST YOU AND THE LEAD PERSON. Subject Matter Expert Personal Comments: • ___________________________ • ___________________________

  2. NQF Safe Practice #5: Pharmacists should actively participate in the medication-use process. Fill in the table below. Use slide #4 for overflow information.

  3. NQF Safe Practice #5: Pharmacists should actively participate in the medication-use process. Leapfrog Deliverables

  4. NQF Safe Practice #5: Pharmacists should actively participate in the medication-use process.

  5. NQF Safe Practices Consensus Evaluation October 2003 Texas Medical Institute of Technology • Subject Matter Expert Input Instructions: • PROVIDE INFORMATION REQUESTED IN TABLE PROVIDED: • Fill in the sections of the table on slide # 2 with your expert interpretation and answers to the questions in the shaded area. • Slide #4 was provided for overflow information that may not all fit on slide # 2. • USE SLIDE # 3 AS YOUR NQF REFERENCE RESOURCE : • The content has been taken directly from the NQF Safe Practices Consensus Report published May 2003. • PLEASE RETURN THE FORMS BY E-MAIL TO THE LEAD PERSON DEFINED IN THE BOX ABOVE. • IF YOU HAVE ANY ADDITIONAL COMMENTS, PLEASE RECORD THEM IN THE BOX TO THE RIGHT. • IF YOU HAVE ANY QUESTIONS, PLEASE CALL OR E-MAIL THE LEAD OR ASSIST PERSONS FOR THE PRACTICE DESIGNATED ABOVE. • THE LEAD PERSON IS RESPONSIBLE TO COLLECT THE INFORMATION YOU SUBMIT AND THE ASSIST PERSON IS AVAILABLE TO ASSIST YOU AND THE LEAD PERSON. Subject Matter Expert Personal Comments: • ___________________________ • ___________________________

  6. NQF Safe Practice #6: Verbal orders should be recorded whenever possible and immediately read back to the prescriber. Fill in the table below. Use slide #4 for overflow information.

  7. NQF Safe Practice #6: Verbal orders should be recorded whenever possible and immediately read back to the prescriber. Leapfrog Deliverables

  8. NQF Safe Practice #6: Verbal orders should be recorded whenever possible and immediately read back to the prescriber.

  9. NQF Safe Practices Consensus Evaluation October 2003 Texas Medical Institute of Technology • Subject Matter Expert Input Instructions: • PROVIDE INFORMATION REQUESTED IN TABLE PROVIDED: • Fill in the sections of the table on slide # 2 with your expert interpretation and answers to the questions in the shaded area. • Slide #4 was provided for overflow information that may not all fit on slide # 2. • USE SLIDE # 3 AS YOUR NQF REFERENCE RESOURCE : • The content has been taken directly from the NQF Safe Practices Consensus Report published May 2003. • PLEASE RETURN THE FORMS BY E-MAIL TO THE LEAD PERSON DEFINED IN THE BOX ABOVE. • IF YOU HAVE ANY ADDITIONAL COMMENTS, PLEASE RECORD THEM IN THE BOX TO THE RIGHT. • IF YOU HAVE ANY QUESTIONS, PLEASE CALL OR E-MAIL THE LEAD OR ASSIST PERSONS FOR THE PRACTICE DESIGNATED ABOVE. • THE LEAD PERSON IS RESPONSIBLE TO COLLECT THE INFORMATION YOU SUBMIT AND THE ASSIST PERSON IS AVAILABLE TO ASSIST YOU AND THE LEAD PERSON. Subject Matter Expert Personal Comments: • ___________________________ • ___________________________

  10. NQF Safe Practice #7: Use only standardized abbreviations and dose designations. Fill in the table below. Use slide #4 for overflow information.

  11. NQF Safe Practice #7: Use only standardized abbreviations and dose designations. Leapfrog Deliverables

  12. NQF Safe Practice #7: Use only standardized abbreviations and dose designations.

More Related